Donafenib Tosilate Tablets
Sponsors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Changsha Taihe Hospital
Conditions
Advanced Gastrointestinal TumorsAdvanced Hepatocellular CarcinomaGastric CancerOesophageal CancerSolid TumorUnresectable Hepatocellular Carcinoma
Phase 1
A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
TerminatedNCT02489201
Start: 2015-07-21End: 2020-10-29Updated: 2023-06-15
Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer
TerminatedNCT02489214
Start: 2016-05-16End: 2019-06-13Updated: 2023-05-08
Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
NCT04503902
Start: 2020-10-15End: 2023-12-31Target: 46Updated: 2022-11-29
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
Active, not recruitingNCT04605185
Start: 2021-01-08End: 2024-12-31Target: 18Updated: 2024-03-06
A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
TerminatedNCT04612712
Start: 2021-01-19End: 2022-06-30Updated: 2026-05-01
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
RecruitingNCT06239298
Start: 2024-05-10End: 2026-05-31Target: 130Updated: 2024-06-14